Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

2014-10-31@08:11:50 ET
Xencor regains rights for rheumatoid arthritis drug from Amgen (DTM)

2014-10-31@01:20:43 ET
Xencor Regains Rights to XmAb5871 (CLM)

2014-10-30@15:00:40 ET
Amgen (AMGN) Trading Near $155.69 Support Level (FBM)

2014-10-30@13:26:45 ET
Next Resistance Level for Amgen (AMGN) is $161.31 (PSM)

2014-10-30@13:24:27 ET
Amgen (AMGN) Breaks Through Resistance at $160.10 (F79)

2014-10-30@11:13:37 ET
Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (MTO)

2014-10-30@09:15:00 ET
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire (PRN)

2014-10-30@05:41:30 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2014-10-29@16:49:21 ET

2014-10-29@15:26:26 ET
Recent 52-Week High Exceeded in Shares of Amgen (AMGN) (F71)

2014-10-29@10:04:55 ET
Positive Bounce Tipped For Singapore Market (ABW)

2014-10-29@09:02:05 ET
Amgen (AMGN) Showing Resistance Near $161.08 (FBM)

2014-10-29@08:11:32 ET
Relatively Good Performance Detected in Shares of Celldex Therapeutics in the Biotechnology Industry (CLDX, VNDA, MNKD, SGMO, AMGN) (F70)

2014-10-29@07:56:38 ET
Upgrade Alert for Amgen (AMGN) (PSM)

2014-10-29@05:28:38 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2014-10-29@05:28:28 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2014-10-28@12:03:33 ET
Biogen Idec has the Highest Free Cash Flow Per Share in the Biotechnology Industry (BIIB, UTHR, AMGN) (F70)